Medico Intercontinental Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Medico Intercontinental Ltd. on BSE

Load latest

Medico Intercontinental Ltd.

14 Feb 2024, 01:06PM

38.30

1.32%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances …

BSE India

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2024, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2023 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results along with Limited Review Report' for the quarter and nine months ended on December 31, 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com. The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:55 PM.

pdf

Medico Intercontinental Ltd.

06 Feb 2024

38.30

1.32%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation …

BSE India

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve The meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 14th February, 2024 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December, 2023 and any other business items as per agenda circulated.

pdf

Medico Intercontinental Ltd.

08 Jan 2024

38.30

1.32%

Company Update

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.

pdf

Medico Intercontinental Ltd.

30 Dec 2023

38.30

1.32%

SAST

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

BSE India

Closure of Trading Window

pdf

Medico Intercontinental Ltd.

28 Nov 2023

38.30

1.32%

SAST

Medico Intercontinental Ltd - 539938 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Dilipkumar Shah

pdf

Medico Intercontinental Ltd.

25 Nov 2023

38.30

1.32%

Company Update

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) …

BSE India

The Company has received disclosure dated 24th November, 2023 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir D Shah, Promoter and Managing Director of the Company.

pdf

Medico Intercontinental Ltd.

24 Nov 2023

38.30

1.32%

SAST

Medico Intercontinental Ltd - 539938 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Dilipkumar Shah

pdf

Medico Intercontinental Ltd.

24 Nov 2023

38.30

1.32%

SAST

Medico Intercontinental Ltd - 539938 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Dilipkumar Shah

pdf

Medico Intercontinental Ltd.

23 Nov 2023

38.30

1.32%

Company Update

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) …

BSE India

The Company has received disclosure dated 23rd November, 2023 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir D Shah, Promoter and Managing Director of the Company.

pdf